<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">epidemiology</journal-id><journal-title-group><journal-title xml:lang="ru">Эпидемиология и Вакцинопрофилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Epidemiology and Vaccinal Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2073-3046</issn><issn pub-type="epub">2619-0494</issn><publisher><publisher-name>«Numicom» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31631/2073-3046-2016-15-1-61-66</article-id><article-id custom-type="elpub" pub-id-type="custom">epidemiology-129</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ВАКЦИНОПРОФИЛАКТИКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>VACCINAL PREVENTION</subject></subj-group></article-categories><title-group><article-title>Вакцинация против гемофильной инфекции типа b в Российской Федерации и за рубежом</article-title><trans-title-group xml:lang="en"><trans-title>Vaccination against Haemophilus influenzae type b in the Russian Federation and Abroad</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Озерецковский</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ozeretskovsky</surname><given-names>N. A.</given-names></name></name-alternatives><email xlink:type="simple">ozeretskovskiy@expmed.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Немировская</surname><given-names>Т. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Nemirovskaya</surname><given-names>T. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Научный центр экспертизы средств медицинского применения» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgeteve Institution «Scientific Centre for Expertise of Medical Products» of the Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>20</day><month>02</month><year>2016</year></pub-date><volume>15</volume><issue>1</issue><fpage>61</fpage><lpage>66</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Озерецковский Н.А., Немировская Т.И., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Озерецковский Н.А., Немировская Т.И.</copyright-holder><copyright-holder xml:lang="en">Ozeretskovsky N.A., Nemirovskaya T.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.epidemvac.ru/jour/article/view/129">https://www.epidemvac.ru/jour/article/view/129</self-uri><abstract><p>Вакцинация против гемофильной инфекции типа b (ХИБ-инфекция), является основным методом защиты от этого заболевания. Эффективность иммунизации подтверждается значительным снижением смертности от гемофильной инфекции. В статье обсуждаются состав современных моно- и комбинированных конъюгированных вакцин, лицензированных в России, США, Великобритании, Канаде и Австралии, а также вопросы тактики и схем иммунизации. Особое внимание уделено вопросам вакцинации лиц с нарушениями иммунной системы, обладающих высокой восприимчивостью к гемофильной инфекции.</p></abstract><trans-abstract xml:lang="en"><p>Vaccination against Haemophilus influenzae type b infection is the principal method of its prophylaxis. This position is supported the results of extensive immunization which leading to significant morbidity decrease. The article discusses compositions of modern conjugated mono and associated vaccines, which has been licenced in Russia, USA, Great Britain, Canada and Australia, tactics and schedules of immunization. The special attention gives to immunocompromised person s vaccination, who possess the high sensibility to the infection.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ХИБ-инфекция</kwd><kwd>ХИБ-вакцины</kwd><kwd>коньюгированные вакцины</kwd><kwd>схема иммунизации</kwd><kwd>национальный календарь профилактических прививок</kwd><kwd>Hib-infection</kwd><kwd>Hib vaccines</kwd><kwd>conjugate vaccines</kwd><kwd>immunization scheme</kwd><kwd>the National Immunization Scheduls</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Haemophilus influenzae type b ( Hib) Vaccination Position Paper - July 2013. WHO. Weekly epidemiological record; 38: 413 - 428.</mixed-citation><mixed-citation xml:lang="en">Haemophilus influenzae type b ( Hib) Vaccination Position Paper – July 2013. WHO. Weekly epidemiological record; 38: 413 – 428.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Prevention and Control of Haemophilus influenzae Type b Disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR; Feb.28, 2014; 63 (1).</mixed-citation><mixed-citation xml:lang="en">Prevention and Control of Haemophilus influenzae Type b Disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR; Feb.28, 2014; 63 (1).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Haemophilus influenzae type b immunization. Bulletins du Centre International de L Enfance; 1992: 33 - 34.</mixed-citation><mixed-citation xml:lang="en">Haemophilus influenzae type b immunization. Bulletins du Centre International de Lʹ Enfance; 1992: 33 – 34.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Haemophilus influenzae type b ( Hib). The Green Book. Immunization against infections desease. 2013; 2 (16): 127 - 143.</mixed-citation><mixed-citation xml:lang="en">Haemophilus influenzae type b ( Hib). The Green Book. Immunization against infections desease. 2013; 2 (16): 127 – 143.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">О взаимодействии территориальных органов и учреждений Роспотребнадзора с Референс-центром по мониторингу за бактериальными менингитами. Письмо Роспотребнадзора от 29 июня 2010 г. № 01/96-20-0-32.</mixed-citation><mixed-citation xml:lang="en">Interaction between Federal Service of Surveillance on Consumer’ Rights Protection and Human Wellbeing (Rospotrebnadzor) territory organs and institutions with Reference Centre for monitoring of bacterial meningitis. Rospotrebnadzor  business letter. June 29, 2010. № 01/96-20-0-32 (in Russia).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Dajani A, Asmar B,Thirumoorthi M. Systemic Haemophilus influenzae disease: an over - view. J. Pediatris 1979; 94 (3): 355 - 364.</mixed-citation><mixed-citation xml:lang="en">Dajani A, Asmar B,Thirumoorthi M. Systemic Haemophilus influenzae disease: an over - view. J. Pediatris 1979; 94 (3): 355 – 364.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chandrasekar PH. Haemophilus meningitis. Доступно на: http://misc.medscape.com/pi/phone/medscapeapp/html/A1164916-business.html.</mixed-citation><mixed-citation xml:lang="en">Chandrasekar P.H. Haemophilus meningitis. Available at: http://misc.medscape.com/pi/phone/medscapeapp/html/A1164916-business.html.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Epidemiology and prevention of vaccine-preventable diseases The Pink Book: Course Textbook - 12th Ed. Second Printing (May 2012). Доступно на: http:// www.cdc.gov/vaccines/pubs/pinkbook/hib.html.</mixed-citation><mixed-citation xml:lang="en">Epidemiology and prevention of vaccine - preventable diseases. The Pink Book: Course textbook – 12th Ed. Second Printing (May 2012). Available at: http://www.cdc.gov/vaccines/pubs/pinkbook/hib.html</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Recommendation of the standing committee on vaccination (STIKO) at the Robert Koch Institute Epidemiologisches Bulletin, 25 aug.,2014; 34: 305 - 340.</mixed-citation><mixed-citation xml:lang="en">Recommendation of the standing committee on vaccination (STIKO) at the Robert Koch Institute epidemiologisches bulletin, 25 aug.,2014; 34: 305 – 340.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Briere E. C., Rubin L., Moro P. L., Colin A., Messonnier N. Prevention and control of Haemophilus influenzae type b disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR; Feb. 28; 2014; 63 (RR01): 1 - 14.</mixed-citation><mixed-citation xml:lang="en">Briere E. C., Rubin L., Moro P. L., Colin A., Messonnier N. Prevention and control of haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR, Feb. 28, 2014 ; 63 (RR01): 1 – 14.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Canadian immunization guide. Part 4. Active Vaccines. Haemophilus influenzae type b Vaccine. 2014. Доступно на: http://www.phac-aspc.gс.ca/publicat/ cig-gci/p04-hea-eng.php.</mixed-citation><mixed-citation xml:lang="en">Canadian Immunization Guide. Part 4. Active Vaccines. Haemophilus influenzae type b Vaccine. 2014. Available at: http://www.phac-aspc.gс.ca/publicat/cig-gci/p04-hea-eng.php</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Groups with special vaccination requirements. The Australian immunization Handbook 10th, 2013. Доступно на: http://www.immunise.health.gov.au/inter-net/ immunize/publishing.nsf.</mixed-citation><mixed-citation xml:lang="en">Groups with special vaccination requirements. The Australian immunization Handbook 10th, 2013. Available at: http://www.immunise.health.gov.au/internet/immunize/publishing.nsf</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">UNICEF-WHO. A statistical reference containing data through 2013. Immunization summary. The 2014 Edition.</mixed-citation><mixed-citation xml:lang="en">UNICEF.WHO. A statistical reference containing data through 2013. Immunization summary. The 2014 Edition.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Haemophilus influenzae infection. Red Book. 29 Edition; American Academy of Pediatrics; 2012: 345 - 352.</mixed-citation><mixed-citation xml:lang="en">Haemophilus influenzae infection. Red Book. 29 Edition; American Academy of Pediatrics; 2012: 345 – 352.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Summary of notifiable diseases United States, 2012. MMWR. Sept 19, 2014; 61 (53): 25.</mixed-citation><mixed-citation xml:lang="en">Summary of notifiable diseases United States, 2012. MMWR. Sept 19, 2014; 61 (53): 25.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Notifiable diseases and neonatality tables. Summary of notifiable diseases. MMWR. Jan. 16. 2015; 64 (01): ND-1-ND-19.</mixed-citation><mixed-citation xml:lang="en">Notifiable diseases and neonatality tables. Summary of notifiable diseases. MMWR. Jan. 16. 2015; 64 (01): ND-1-ND-19.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">WHO vaccine-preventable diseases: monitoring system.2014. Global summary. Доступно на: http:// http://www.//apps.WHO.int/immunization monitoring/global summary/time series.</mixed-citation><mixed-citation xml:lang="en">WHO vaccine-preventable diseases: monitoring system.2014.Global summary. Available at: http:// http://www.//apps.WHO.int/immunization monitoring/global summary/time series.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Global routine vaccination coverage, 2013.Weekly epidemiological record. 21 Nov., 2014; 47 (89): 517 - 528.</mixed-citation><mixed-citation xml:lang="en">Global routine vaccination coverage, 2013.Weekly epidemiological record. 21 Nov., 2014; 47 (89): 517 – 528.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Global immunization data. WHO. UNICEF. July. 2014. Доступно на: http:// www.who.int/immunization/monitoring surveillance/global immunization data.pdf</mixed-citation><mixed-citation xml:lang="en">Global immunization data. WHO. UNICEF. July. 2014. Available at: http://www.who.int/immunization/monitoring surveillance/global immunization data.pdf</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Национальный календарь профилактических прививок; Российская газета;; 2014, 16 мая; 6381.</mixed-citation><mixed-citation xml:lang="en">National immunization schedule. Rossiiskaya Gazeta (Russian newspaper) № 6381, 2014, May.16 (in Russia).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Эпидемиология и вакцинопрофилактика инфекции, вызываемой Haemophilus influenzae типа b. Методические рекомендации № 3.3.1.0001-10.</mixed-citation><mixed-citation xml:lang="en">Haemophilus influenzae type b infection. Epidemiolology and vaccinoprophylactis. Methodological recommendation. № 3.3.1.0001-10 (in Russia).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">WHO information sheet observed rate of vaccine Haemophilus influenzae type b (Hib) vaccine. April 2012. Доступно на: http:// www.who.int/vaccine Hib safety/initiative/tools/ Hib Vaccine - rates - information - sheet.pdf</mixed-citation><mixed-citation xml:lang="en">WHO information Sheet observed rate of vaccine Haemophilus influenzae type b (Hib) vaccine. April 2012. Available at: http:// www.who.int/vaccine Hib safety/initiative/tools/ Hib Vaccine - rates – information – sheet.pdf</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Haemophilus b conjugated vaccines for prevention of Haemophilus influenzae type b disease among infants and children. Recommendations of ACIP MMWR, Jan.11; 1991 RRI; (40): 1 - 7.</mixed-citation><mixed-citation xml:lang="en">Haemophilus b conjugated vaccines for prevention of Haemophilus influenzae type b disease among infants and children. Recommendations of ACIP. MMWR, Jan.11; 1991; 40 (RRI): 1 – 7.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Bohle K., Davis R., Marcy S. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics, 2003, oct., 112 (4), 815 - 820.</mixed-citation><mixed-citation xml:lang="en">Bohle K., Davis R., Marcy S. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics, 2003, oct., 112 (4): 815 – 820.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Moro PL., Jankosky C., Mensehik D. Adverse Events follow Haemophilus influenzae type b vaccine in the Vaccine Adverse Reporting System 1990 - 2013. The Journal of Pediatrics. Jan.2015, 166, 4, 992 - 997.</mixed-citation><mixed-citation xml:lang="en">Moro P.L., Jankosky C., Mensehik D. Adverse Events follow Haemophilus influenzae type b vaccine in the vaccine adverse reporting system 1990 – 2013. The Journal of Pediatrics. Jan.2015; 166 (4): 992 – 997.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Медицинские противопоказания к проведению профилактических прививок препаратами национального календаря прививок. Методические указания МУ 3.3.1.1095-02.</mixed-citation><mixed-citation xml:lang="en">The contraindications for immunization vaccines of national schedula. Methodological Indications. М I 3.3.1.1095-02 (in Russia).</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Rubin L.G., Rubin L G. Levin M.J., Ljungman P, Davies E.G., Avery R. at al. 2013 IDSA Clinical practice guideline for vaccination of the immunocompromised host. IDSA Guidelines. Clin.Inf. Dis., 2014; 58 (3): 44 - 87.</mixed-citation><mixed-citation xml:lang="en">Rubin L.G., Levin M.J., Davies E.G., Tomblyn M.,Bousvaros A., at all. 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host. IDSA Guidelines. Clin.Inf. Dis., 2014; 58 (3): 44 – 87.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
